Hanmi Pharm 2 innovative new drugs for rare disease treatment… FDA approval for Phase 2 clinical trial
The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical
Esther Yeo, “Chairman of the Korea Centers for Disease Control and Prevention Jung Eun-kyung and Seoul National University Medical School Alumni”… Until the request for support